KUROS

WIPO WIPO 2002

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark KUROS was filed as Word mark on 08/28/2002 at the World Intellectual Property Organization.

Trademark Details Last update: October 11, 2022

Trademark form Word mark
File reference 799423
Register number 502495
Countries Australia em United States of America (USA)
Base trademark CH No. 502495, March 14, 2002
Application date August 28, 2002
Expiration date August 28, 2032

Trademark owner

Wagistrasse 25
8952 Schlieren
CH

Trademark representatives

Friedtalweg 5 9500 Wil SG CH

goods and services

03 Biotechnological products for cosmetic use, namely, biotechnological products for cosmetic use containing in particular hormones and growth factors, i.e. substances which stimulate the growth of an organism or maintain it; products for permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous soft tissues, in particular fat and muscle tissues, for cosmetic use; synthetic and/or natural products for cosmetic use, consisting in particular of fibrin and/or polyethylene glycol, for the retention or the delayed release of peptides or proteins, in particular growth factors and hormones, i.e. substances which stimulate the growth of an organism or maintain it
05 Pharmaceutical products and preparations such as protein and/or peptide preparations, in particular for local support of formation or regeneration of missing or damaged body parts, in particular of hard or soft tissues, in particular skin or bones; goods of synthetic and/or natural origin for medical use, in particular consisting of fibrin and/or polyethylene glycol, for the retention or the delayed release of peptides or proteins, in particular growth factors and hormones, i.e. substances which stimulate the growth of an organism or maintain it; hygiene preparations; biomedical products, biotechnology products for medical use, in particular growth factors and hormones, i.e. substances which stimulate the growth of an organism or maintain it; products for medical use for the permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous hard or soft tissues, in particular for bones, intervertebral discs, cartilage, fat and muscle tissues; permanent or temporary adhesives and sealing substances compatible with the body, in particular for human or animal organs, soft and hard tissues for medical use; separation products for medical use compatible with the body, intended to prevent organs and/or soft parts from sticking together; modified implants and transplants in endogenous material, tissues, cells and/or molecules for replacing and/or assisting the function of missing or damaged body parts; endogenous soft tissues, in particular for fat tissue and tissue replacement; endogenous hard and soft tissues, in particular for bones for transplantation purposes, natural biomaterials for bone, cartilage, vessel, tissue and fat tissue replacement
10 Synthetic biomaterials for the substitution of tissue, for the recovery, maintenance and/or the repair of the function of diseased or damaged human or animal tissue (Tissue Engineering); synthetic implants and transplants and modified implants and transplants, tissue, cells and/or molecules for replacing and/or assisting with the function of missing or damaged body parts; synthetic hard and soft tissues, in particular synthetic bones for transplantation and diagnostic purposes, synthetic biomaterials for bone, vessel, tissue and fat tissue substitution; modified implants and transplants in endogenous material, tissue, cells and/or molecules, for replacing and/or assisting with the function of missing or damaged body parts
41 Training and further training, in particular for doctors and medical personnel
42 Research, development and advice in the field of biomedicine and biomaterials; services provided by a pharmaceutical or biotechnological company, in particular by a pharmacologist, a biochemist, a scientist specialized in biomaterials or a biotechnologist in the field of tissue engineering; scientific research services for medical use; legal advice/lawyer or industrial property consultant services; services in the field of quality assurance and certification requirements regarding pharmaceutical products and medical technology products
44 Services provided by a doctor; advice in medical affairs

Trademark history

Date Document number Area Entry
September 16, 2022 2022/41 Gaz AU Rejection
August 29, 2022 CH Correction
August 28, 2022 2022/39 Gaz Extension
January 11, 2021 2021/2 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 12, 2019 2019/24 Gaz EM RAW: Seniority Removed
April 29, 2019 2019/18 Gaz EM Rejection
December 15, 2018 2018/51 Gaz US Rejection
August 10, 2018 2018/45 Gaz CH Correction
August 28, 2012 2012/35 Gaz Extension
September 24, 2004 2004/33 Gaz ES RAW: Final Reversing Refusal
February 16, 2004 2004/4 Gaz ES Rejection
August 28, 2002 2003/7 Gaz CH Registration
Partial deletion

ID: 14799423